Biogen revenue 2007-2023

This statistic shows the revenue and net income of biotechnology company Biogen from 2007 to 2023. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2023, Biogen generated revenues worth around 9.8 billion U.S. dollars.

本统计数据显示了生物技术公司Biogen自2007年至2023年的收入和净收入情况。Biogen Inc.是一家位于马萨诸塞州的生物技术公司，专注于神经性疾病、自身免疫性疾病和癌症药物的研发。截至2023年，Biogen实现了约98亿美元的营业收入。